Gillian Edwards
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Gillian Edwards has a total of 25 co-authors. Here are the top co-authors by number of shared publications:
A H Weston
The University of Manchester, Manchester, UK
3 shared publications- Erika Harno
Division of Diabetes, Endocrinology and Gastroenterology, School of Medical Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester M13 9PT, UK
2 shared publications M Absi
Faculty of Life Sciences, The University of Manchester Manchester, UK
2 shared publicationsA R Geraghty
Faculty of Life Sciences, The University of Manchester Manchester, UK
1 shared publicationA. Geraghty
Faculty of Life Sciences, University of Manchester, Manchester, UK
1 shared publicationA. H. Weston
Faculty of Life Sciences, University of Manchester, UK
1 shared publication
Latest Publications
- Open Access
- 12 March 2013
- Published by Wiley in British Journal of Pharmacology
- Vol. 169 (7) , 1500-1509
Stimulated release of a hyperpolarizing factor (ADHF) from mesenteric artery perivascular adipose tissue: involvement of myocyte BKCa channels and adiponectin
Background and Purpose: Perivascular adipose tissue (PVAT) releases adipocyte‐derived hyperpolarizing factors (ADHFs) that may partly act by opening myocyte K+ channels. The present study in rat and mouse mesenteric arteries aimed to identify the myocyte K+ channel activated by PVAT and to determine whether adiponectin contributed to the hyperpolarizing effects of PVAT.Experimental Approach: Myocyte membrane potential was recorded from de‐endothelialized, non‐contracted rat and mouse mesenteric arteries in the presence and absence of PVAT.Key Results: The β3‐adrenoceptor agonist, CL‐316,243 (10 μM), generated PVAT‐dependent, iberiotoxin‐sensitive myocyte hyperpolarizations resulting from BKCa channel opening and which were partially blocked by L‐NMMA (100 μM). Adiponectin (5 μg·mL−1) also produced iberiotoxin‐sensitive hyperpolarizations in PVAT‐denuded arterioles. Activation of myocyte AMP‐activated protein kinase (AMPK) using 5 μM A‐769662 also induced BKCa‐mediated hyperpolarizations. Dorsomorphin abolished hyperpolarizations to CL‐316,243, adiponectin and A‐769662. In vessels from Adipo−/− mice, hyperpolarizations to CL‐316,243 were absent whereas those to A‐769662 and adiponectin were normal. In rat vessels, adipocyte‐dependent hyperpolarizations were blocked by glibenclamide and clotrimazole but those to NS1619 (33 μM) were unaltered.Conclusions and Implications: Under basal, non‐contracted conditions, β3‐adrenoceptor stimulation of PVAT releases an ADHF, which is probably adiponectin. This activates AMPK to open myocyte BKCa channels indirectly and additionally liberates NO, which also contributes to the observed PVAT‐dependent myocyte hyperpolarizations. Clotrimazole and glibenclamide each reversed hyperpolarizations to adiponectin and A‐769662, suggesting the involvement of myocyte TRPM4 channels in the ADHF‐induced myocyte electrical changes mediated via the opening of BKCa channels.
- 12 March 2013
- Published by Wiley in British Journal of Pharmacology
- Vol. 169 (7) , 1500-1509
Open AccessStimulated release of a hyperpolarizing factor (ADHF) from mesenteric artery perivascular adipose tissue: involvement of myocyte BKCa channels and adiponectin
Background and Purpose: Perivascular adipose tissue (PVAT) releases adipocyte‐derived hyperpolarizing factors (ADHFs) that may partly act by opening myocyte K+ channels. The present study in rat and mouse mesenteric arteries aimed to identify the myocyte K+ channel activated by PVAT and to determine whether adiponectin contributed to the hyperpolarizing effects of PVAT.Experimental Approach: Myocyte membrane potential was recorded from de‐endothelialized, non‐contracted rat and mouse mesenteric arteries in the presence and absence of PVAT.Key Results: The β3‐adrenoceptor agonist, CL‐316,243 (10 μM), generated PVAT‐dependent, iberiotoxin‐sensitive myocyte hyperpolarizations resulting from BKCa channel opening and which were partially blocked by L‐NMMA (100 μM). Adiponectin (5 μg·mL−1) also produced iberiotoxin‐sensitive hyperpolarizations in PVAT‐denuded arterioles. Activation of myocyte AMP‐activated protein kinase (AMPK) using 5 μM A‐769662 also induced BKCa‐mediated hyperpolarizations. Dorsomorphin abolished hyperpolarizations to CL‐316,243, adiponectin and A‐769662. In vessels from Adipo−/− mice, hyperpolarizations to CL‐316,243 were absent whereas those to A‐769662 and adiponectin were normal. In rat vessels, adipocyte‐dependent hyperpolarizations were blocked by glibenclamide and clotrimazole but those to NS1619 (33 μM) were unaltered.Conclusions and Implications: Under basal, non‐contracted conditions, β3‐adrenoceptor stimulation of PVAT releases an ADHF, which is probably adiponectin. This activates AMPK to open myocyte BKCa channels indirectly and additionally liberates NO, which also contributes to the observed PVAT‐dependent myocyte hyperpolarizations. Clotrimazole and glibenclamide each reversed hyperpolarizations to adiponectin and A‐769662, suggesting the involvement of myocyte TRPM4 channels in the ADHF‐induced myocyte electrical changes mediated via the opening of BKCa channels.
- 1 March 2011
- Published by Wiley in Acta Physiologica
- Vol. 203 (1) , 127-137
The vascular extracellular calcium-sensing receptor: an update
The extracellular calcium-sensing receptor (CaR) was first described in the parathyroid gland. Recent studies have shown that the CaR is also expressed in blood vessels, especially in the endothelial and adventitial layers but its physiological function is still not clear. However, an understanding of its possible role(s) in the vasculature (perivascular-neurones, heart and blood vessels) is important because of the use of synthetic positive allosteric CaR modulators in hyperparathyroidism and the potential importance of negative modulators in the treatment of osteoporosis. In this review, the effects of CaR activation and inhibition are detailed and the possible role of the CaR as both an amplifier and attenuator of myo-endothelial coupling in the vasculature is described.
- 1 March 2011
- Published by Wiley in Acta Physiologica
- Vol. 203 (1) , 127-137
The vascular extracellular calcium-sensing receptor: an update
The extracellular calcium-sensing receptor (CaR) was first described in the parathyroid gland. Recent studies have shown that the CaR is also expressed in blood vessels, especially in the endothelial and adventitial layers but its physiological function is still not clear. However, an understanding of its possible role(s) in the vasculature (perivascular-neurones, heart and blood vessels) is important because of the use of synthetic positive allosteric CaR modulators in hyperparathyroidism and the potential importance of negative modulators in the treatment of osteoporosis. In this review, the effects of CaR activation and inhibition are detailed and the possible role of the CaR as both an amplifier and attenuator of myo-endothelial coupling in the vasculature is described.
- Open Access
- 24 May 2010
- Published by Wiley in British Journal of Pharmacology
- Vol. 160 (4) , 836-843
Impairment of endothelial SKCa channels and of downstream hyperpolarizing pathways in mesenteric arteries from spontaneously hypertensive rats
Background and purpose: Previous studies have shown that endothelium‐dependent hyperpolarization of myocytes is reduced in resistance arteries from spontaneously hypertensive rats (SHRs). The aim of the present study was to determine whether this reflects down‐regulation of endothelial K+ channels or their associated pathways.Experimental approach: Changes in vascular K+ channel responses and expression were determined by a combination of membrane potential recordings and Western blotting.Key results: Endothelium‐dependent myocyte hyperpolarizations induced by acetylcholine, 6,7‐dichloro‐1H‐indole‐2,3‐dione 3‐oxime (NS309) (opens small‐ and intermediate‐conductance calcium‐sensitive K+ channels, SKCa and IKCa, respectively) or cyclohexyl‐[2‐(3,5‐dimethyl‐pyrazol‐1‐yl)‐6‐methyl‐pyrimidin‐4‐yl]‐amine (SKCa opener) were reduced in mesenteric arteries from SHRs. After blocking SKCa channels with apamin, hyperpolarizations to acetylcholine and NS309 in SHR arteries were similar to those of controls. Hyperpolarization to 5 mM KCl was reduced in SHR arteries due to loss of the Ba2+‐sensitive, inward‐rectifier channel (KIR) component; the contribution of ouabain‐sensitive, Na+/K+‐ATPases was unaffected. Protein expression of both SKCa and KIR channels was reduced in SHR arteries; the caveolin‐1 monomer/dimer ratio was increased.Conclusions and implications: In SHRs, the distinct pathway that generates endothelium‐dependent hyperpolarization in vascular myocyte by activation of IKCa channels and Na+/K+‐ATPases remains intact. The second pathway, initiated by endothelial SKCa channel activation and amplified by KIR opening on both endothelial cells and myocytes is compromised in SHRs due to down‐regulation of both SKCa and KIR and to changes in caveolin‐1 oligomers. These impairments in the SKCa–KIR pathway shed new light on vascular control mechanisms and on the underlying vascular changes in hypertension.This article is commented on by Garland, pp. 833–835 of this issue. To view this commentary visit http://dx.doi.org/10.1111/j.1476‐5381.2010.00692.x
- 24 May 2010
- Published by Wiley in British Journal of Pharmacology
- Vol. 160 (4) , 836-843
Open AccessImpairment of endothelial SKCa channels and of downstream hyperpolarizing pathways in mesenteric arteries from spontaneously hypertensive rats
Background and purpose: Previous studies have shown that endothelium‐dependent hyperpolarization of myocytes is reduced in resistance arteries from spontaneously hypertensive rats (SHRs). The aim of the present study was to determine whether this reflects down‐regulation of endothelial K+ channels or their associated pathways.Experimental approach: Changes in vascular K+ channel responses and expression were determined by a combination of membrane potential recordings and Western blotting.Key results: Endothelium‐dependent myocyte hyperpolarizations induced by acetylcholine, 6,7‐dichloro‐1H‐indole‐2,3‐dione 3‐oxime (NS309) (opens small‐ and intermediate‐conductance calcium‐sensitive K+ channels, SKCa and IKCa, respectively) or cyclohexyl‐[2‐(3,5‐dimethyl‐pyrazol‐1‐yl)‐6‐methyl‐pyrimidin‐4‐yl]‐amine (SKCa opener) were reduced in mesenteric arteries from SHRs. After blocking SKCa channels with apamin, hyperpolarizations to acetylcholine and NS309 in SHR arteries were similar to those of controls. Hyperpolarization to 5 mM KCl was reduced in SHR arteries due to loss of the Ba2+‐sensitive, inward‐rectifier channel (KIR) component; the contribution of ouabain‐sensitive, Na+/K+‐ATPases was unaffected. Protein expression of both SKCa and KIR channels was reduced in SHR arteries; the caveolin‐1 monomer/dimer ratio was increased.Conclusions and implications: In SHRs, the distinct pathway that generates endothelium‐dependent hyperpolarization in vascular myocyte by activation of IKCa channels and Na+/K+‐ATPases remains intact. The second pathway, initiated by endothelial SKCa channel activation and amplified by KIR opening on both endothelial cells and myocytes is compromised in SHRs due to down‐regulation of both SKCa and KIR and to changes in caveolin‐1 oligomers. These impairments in the SKCa–KIR pathway shed new light on vascular control mechanisms and on the underlying vascular changes in hypertension.This article is commented on by Garland, pp. 833–835 of this issue. To view this commentary visit http://dx.doi.org/10.1111/j.1476‐5381.2010.00692.x
- 1 June 2008
- Published by Wiley in British Journal of Pharmacology
- Vol. 154 (3) , 652-662
The expression and function of Ca2+‐sensing receptors in rat mesenteric artery; comparative studies using a model of type II diabetes
Background and purpose: The extracellular calcium‐sensing receptor (CaR) in vascular endothelial cells activates endothelial intermediate‐conductance, calcium‐sensitive K+ channels (IKCa) indirectly leading to myocyte hyperpolarization. We determined whether CaR expression and function was modified in a rat model of type II diabetes.Experimental approach: Pressure myography, western blotting, sharp microelectrode and K+‐selective electrode recordings were used to investigate the functional expression of the CaR and IKCa in rat mesenteric arteries.Key results: Myocyte hyperpolarization to the CaR activator calindol was inhibited by Calhex 231. U46619‐induced vessel contraction elevated the extracellular [K+] around the myocytes, and inhibition of this ‘K+ cloud’ by iberiotoxin was needed to reveal calindol‐induced vasodilatations. These were antagonized by Calhex 231 and significantly smaller in Zucker diabetic fatty rat (ZDF) vessels than in Zucker lean (ZL) controls. Myocyte hyperpolarizations to calindol were also smaller in ZDF than in ZL arteries. In ZDF vessels, endothelial cell CaR protein expression was reduced; IKCa expression was also diminished, but IKCa‐generated hyperpolarizations mediated by 1‐EBIO were unaffected.Conclusions and implications: The reduced CaR‐mediated hyperpolarizing and vasodilator responses in ZDF arteries result from a decrease in CaR expression, rather than from a modification of IKCa channels. Detection of CaR‐mediated vasodilatation required the presence of iberiotoxin, suggesting a CaR contribution to vascular diameter, that is, inversely related to the degree of vasoconstriction. Compromise of the CaR pathway would favour the long‐term development of a higher basal vascular tone and could contribute to the vascular complications associated with type II diabetes.British Journal of Pharmacology (2008) 154, 652–662; doi:10.1038/bjp.2008.108; published online 14 April 2008
- 1 June 2008
- Published by Wiley in British Journal of Pharmacology
- Vol. 154 (3) , 652-662
The expression and function of Ca2+‐sensing receptors in rat mesenteric artery; comparative studies using a model of type II diabetes
Background and purpose: The extracellular calcium‐sensing receptor (CaR) in vascular endothelial cells activates endothelial intermediate‐conductance, calcium‐sensitive K+ channels (IKCa) indirectly leading to myocyte hyperpolarization. We determined whether CaR expression and function was modified in a rat model of type II diabetes.Experimental approach: Pressure myography, western blotting, sharp microelectrode and K+‐selective electrode recordings were used to investigate the functional expression of the CaR and IKCa in rat mesenteric arteries.Key results: Myocyte hyperpolarization to the CaR activator calindol was inhibited by Calhex 231. U46619‐induced vessel contraction elevated the extracellular [K+] around the myocytes, and inhibition of this ‘K+ cloud’ by iberiotoxin was needed to reveal calindol‐induced vasodilatations. These were antagonized by Calhex 231 and significantly smaller in Zucker diabetic fatty rat (ZDF) vessels than in Zucker lean (ZL) controls. Myocyte hyperpolarizations to calindol were also smaller in ZDF than in ZL arteries. In ZDF vessels, endothelial cell CaR protein expression was reduced; IKCa expression was also diminished, but IKCa‐generated hyperpolarizations mediated by 1‐EBIO were unaffected.Conclusions and implications: The reduced CaR‐mediated hyperpolarizing and vasodilator responses in ZDF arteries result from a decrease in CaR expression, rather than from a modification of IKCa channels. Detection of CaR‐mediated vasodilatation required the presence of iberiotoxin, suggesting a CaR contribution to vascular diameter, that is, inversely related to the degree of vasoconstriction. Compromise of the CaR pathway would favour the long‐term development of a higher basal vascular tone and could contribute to the vascular complications associated with type II diabetes.British Journal of Pharmacology (2008) 154, 652–662; doi:10.1038/bjp.2008.108; published online 14 April 2008
- Open Access
- 1 June 2007
- Published by Wiley in British Journal of Pharmacology
- Vol. 151 (3) , 332-340
Effects of methyl β‐cyclodextrin on EDHF responses in pig and rat arteries; association between SKCa channels and caveolin‐rich domains
Background and purpose: The small and intermediate conductance, Ca2+‐sensitive K+ channels (SKCa and IKCa, respectively) which are pivotal in the EDHF pathway may be differentially activated. The importance of caveolae in the functioning of IKCa and SKCa channels was investigated.Experimental approach: The effect of the caveolae‐disrupting agent methyl‐β‐cyclodextrin (MβCD) on IKCa and SKCa localization and function was determined.Key results: EDHF‐mediated, SKCa‐dependent myocyte hyperpolarizations evoked by acetylcholine in rat mesenteric arteries (following blockade of IKCa with TRAM‐34) were inhibited by MβCD. Hyperpolarizations evoked by direct SKCa channel activation (using NS309 in the presence of TRAM‐34) were also inhibited by MβCD, an effect reversed by cholesterol. In contrast, IKCa‐dependent hyperpolarizations (in the presence of apamin) were unaffected by MβCD. Similarly, in porcine coronary arteries, EDHF‐mediated, SKCa‐dependent (but not IKCa‐dependent) endothelial cell hyperpolarizations evoked by substance P were inhibited by MβCD. In mesenteric artery homogenates subjected to sucrose‐density centrifugation, caveolin‐1 and SK3 (SKCa) proteins but not IK1 (IKCa) protein migrated to the buoyant, caveolin‐rich fraction. MβCD pretreatment redistributed caveolin‐1 and SK3 proteins into more dense fractions. In immunofluorescence images of porcine coronary artery endothelium, SK3 (but not IK1) and caveolin‐1 were co‐localized. Furthermore, caveolin‐1 immunoprecipitates prepared from native porcine coronary artery endothelium contained SK3 but not IK1 protein.Conclusions and Implications: These data provide strong evidence that endothelial cell SKCa channels are located in caveolae while the IKCa channels reside in a different membrane compartment. These studies reveal cellular organisation as a further complexity in the EDHF pathway signalling cascade.British Journal of Pharmacology (2007) 151, 332–340; doi:10.1038/sj.bjp.0707222
- 1 June 2007
- Published by Wiley in British Journal of Pharmacology
- Vol. 151 (3) , 332-340
Open AccessEffects of methyl β‐cyclodextrin on EDHF responses in pig and rat arteries; association between SKCa channels and caveolin‐rich domains
Background and purpose: The small and intermediate conductance, Ca2+‐sensitive K+ channels (SKCa and IKCa, respectively) which are pivotal in the EDHF pathway may be differentially activated. The importance of caveolae in the functioning of IKCa and SKCa channels was investigated.Experimental approach: The effect of the caveolae‐disrupting agent methyl‐β‐cyclodextrin (MβCD) on IKCa and SKCa localization and function was determined.Key results: EDHF‐mediated, SKCa‐dependent myocyte hyperpolarizations evoked by acetylcholine in rat mesenteric arteries (following blockade of IKCa with TRAM‐34) were inhibited by MβCD. Hyperpolarizations evoked by direct SKCa channel activation (using NS309 in the presence of TRAM‐34) were also inhibited by MβCD, an effect reversed by cholesterol. In contrast, IKCa‐dependent hyperpolarizations (in the presence of apamin) were unaffected by MβCD. Similarly, in porcine coronary arteries, EDHF‐mediated, SKCa‐dependent (but not IKCa‐dependent) endothelial cell hyperpolarizations evoked by substance P were inhibited by MβCD. In mesenteric artery homogenates subjected to sucrose‐density centrifugation, caveolin‐1 and SK3 (SKCa) proteins but not IK1 (IKCa) protein migrated to the buoyant, caveolin‐rich fraction. MβCD pretreatment redistributed caveolin‐1 and SK3 proteins into more dense fractions. In immunofluorescence images of porcine coronary artery endothelium, SK3 (but not IK1) and caveolin‐1 were co‐localized. Furthermore, caveolin‐1 immunoprecipitates prepared from native porcine coronary artery endothelium contained SK3 but not IK1 protein.Conclusions and Implications: These data provide strong evidence that endothelial cell SKCa channels are located in caveolae while the IKCa channels reside in a different membrane compartment. These studies reveal cellular organisation as a further complexity in the EDHF pathway signalling cascade.British Journal of Pharmacology (2007) 151, 332–340; doi:10.1038/sj.bjp.0707222
- 1 July 2005
- Published by Wiley in British Journal of Pharmacology
- Vol. 145 (6) , 775-784
Bradykinin‐induced, endothelium‐dependent responses in porcine coronary arteries: involvement of potassium channel activation and epoxyeicosatrienoic acids
In coronary arteries, bradykinin opens endothelial intermediate‐ and small‐conductance Ca2+‐sensitive K+ channels (IKCa and SKCa) and, additionally, releases epoxyeicosatrienoic acids (EETs) from the endothelium. To clarify the involvement of these pathways in endothelium‐dependent myocyte hyperpolarization, bradykinin‐induced electrical changes in endothelial cells and myocytes of porcine coronary arteries (following nitric oxide (NO) synthase and cyclooxygenase inhibition) were measured using sharp microelectrodes. Hyperpolarization of endothelial cells by bradykinin (27.0±0.9 mV, n=4) was partially inhibited (74%) by blockade of IKCa and SKCa channels using 10 μM TRAM‐39 (2‐(2‐chlorophenyl)‐2,2‐diphenylacetonitrile) plus 100 nM apamin (leaving an iberiotoxin‐sensitive component), whereas the response to substance P was abolished. After gap junction blockade with HEPES, (N‐(2‐hydroxyethyl)piperazine‐N′‐(2‐ethanesulphonic acid)) hyperpolarization of the endothelium by 100 nM bradykinin was abolished by TRAM‐39 plus apamin, whereas myocyte hyperpolarization still occurred (12.9±1.0 mV, n=4). The residual hyperpolarizations to 100 nM bradykinin were antagonized by the EET antagonist, 14,15‐EEZE (14,15‐epoxyeicosa‐5(Z)‐enoic acid) (10 μM), and abolished by iberiotoxin. Bradykinin‐induced myocyte hyperpolarizations were also reduced by 14,15‐EEZE‐mSI (14,15‐EEZE‐methylsulfonylimide) (5,6‐ and 14,15‐EET antagonist), whereas those to exogenous 11,12‐EET were unaffected. These data show that bradykinin‐induced hyperpolarization of endothelial cells (due to the opening of IKCa and SKCa channels) is electrotonically transferred to the myocytes via gap junctions. Bradykinin (but not substance P) also hyperpolarizes myocytes by a mechanism (independent of endothelial cell hyperpolarization) which involves endothelial cell production of EETs (most likely 14,15‐ and/or 11,12‐EET). These open endothelial IKCa and SKCa channels and also activate large‐conductance calcium‐sensitive K+ channels (BKCa) on the surrounding myocytes. British Journal of Pharmacology (2005) 145, 775–784. doi:10.1038/sj.bjp.0706256
- 1 July 2005
- Published by Wiley in British Journal of Pharmacology
- Vol. 145 (6) , 775-784
Bradykinin‐induced, endothelium‐dependent responses in porcine coronary arteries: involvement of potassium channel activation and epoxyeicosatrienoic acids
In coronary arteries, bradykinin opens endothelial intermediate‐ and small‐conductance Ca2+‐sensitive K+ channels (IKCa and SKCa) and, additionally, releases epoxyeicosatrienoic acids (EETs) from the endothelium. To clarify the involvement of these pathways in endothelium‐dependent myocyte hyperpolarization, bradykinin‐induced electrical changes in endothelial cells and myocytes of porcine coronary arteries (following nitric oxide (NO) synthase and cyclooxygenase inhibition) were measured using sharp microelectrodes. Hyperpolarization of endothelial cells by bradykinin (27.0±0.9 mV, n=4) was partially inhibited (74%) by blockade of IKCa and SKCa channels using 10 μM TRAM‐39 (2‐(2‐chlorophenyl)‐2,2‐diphenylacetonitrile) plus 100 nM apamin (leaving an iberiotoxin‐sensitive component), whereas the response to substance P was abolished. After gap junction blockade with HEPES, (N‐(2‐hydroxyethyl)piperazine‐N′‐(2‐ethanesulphonic acid)) hyperpolarization of the endothelium by 100 nM bradykinin was abolished by TRAM‐39 plus apamin, whereas myocyte hyperpolarization still occurred (12.9±1.0 mV, n=4). The residual hyperpolarizations to 100 nM bradykinin were antagonized by the EET antagonist, 14,15‐EEZE (14,15‐epoxyeicosa‐5(Z)‐enoic acid) (10 μM), and abolished by iberiotoxin. Bradykinin‐induced myocyte hyperpolarizations were also reduced by 14,15‐EEZE‐mSI (14,15‐EEZE‐methylsulfonylimide) (5,6‐ and 14,15‐EET antagonist), whereas those to exogenous 11,12‐EET were unaffected. These data show that bradykinin‐induced hyperpolarization of endothelial cells (due to the opening of IKCa and SKCa channels) is electrotonically transferred to the myocytes via gap junctions. Bradykinin (but not substance P) also hyperpolarizes myocytes by a mechanism (independent of endothelial cell hyperpolarization) which involves endothelial cell production of EETs (most likely 14,15‐ and/or 11,12‐EET). These open endothelial IKCa and SKCa channels and also activate large‐conductance calcium‐sensitive K+ channels (BKCa) on the surrounding myocytes. British Journal of Pharmacology (2005) 145, 775–784. doi:10.1038/sj.bjp.0706256